Pinterest • The world’s catalogue of ideas

Sun Pharma gains after USFDA approval:Sun Pharmaceutical Industries advanced almost a percent to Rs 841.75 on BSE after the company said it received US drug regulator's approval for abbreviated new drug application for generic version of Glumetza tablets.The company will announce Q1 results on 12 August 2016.

Sun Pharmaceuticals Industries Ltd is currently trading at Rs. 849, up by 8.6 points or 1.02% from its previous closing of Rs. 839.7 - See more at: http://ways2capital-equitytips.blogspot.in/2015/09/sun-pharmaceutical-may-divest.html#sthash.CPXETRiL.dpuf

heart 1

"Карепрост" для роста ресниц, 3 мл. /Careprost/Sun Pharmaceutical /15/

Sun Pharmaceutical Industries Ltd announced that one of its subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Gleevec , Imatinib Mesylate tablets 100mg and 400mg Imatinib Mesylate tablets,

Here’s a round-up of the stories thus far: Reuters: FDA bans imports from Sun Pharma plant in India crackdown The U.S. Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Sun Pharmaceutical Industries Ltd’s plant at Karkhadi in the western state of Gujarat, in the latest quality blow for India’s drug sector. …

Sun Pharmaceutical Industries Ltd’s southward journey continues for yet another trading session. The scrip is currently trading 1.3% lower at Rs. 709.15 on BSE, which is a 16-month low level. - See more at: http://ways2capital-equitytips.blogspot.in/2015/11/sun-pharma-falls-13-pays-rs-500-cr.html#sthash.7RMIbaax.dpuf

Sun Pharmaceuticals Industries Ltd is currently trading at Rs. 913, up by 1.7% from its previous closing of Rs. 898.2 on the BSE. - See more at: http://ways2capital-review.blogspot.in/2015/10/sun-pharma-up-17-ranbaxy.html#sthash.G7MF6dF5.dpuf

heart 1

Investors bought more shares of Sun Pharmaceutical Industries on Monday on settlement of litigation with the US company. The stock rallied more than 4 percent to hit a record high of Rs 1,124.35. The drug maker has entered into a settlement pact with US-based The Medicines Company for settling the lawsuit filed against it by the later for generic Angiomax. - See more at: http://ways2capital.blogspot.in/2015/04/sun-pharma-up-4.html#sthash.M90lO67v.dpuf

heart 1

Sun Pharma Recalls Effexor in U.S.

Sun Pharmaceutical Industries Ltd. has recalled 68,000 bottles of the antidepressant Effexor in the U.S., in the second recall of the drug this year, the U.S. Food and Drug Administration said http://online.wsj.com/articles/sun-pharma-recalls-effexor-in-u-s-1416297616?mod=WSJ_LatestHeadlines

#SunPharmaceutical gains after buying #Novartis cancer drug #Odomzo